%D8%A3%D9%83%D8%B3%D9%8A%D8%AF_%D8%A7%D9%84%D8%B2%D8%B1%D9%86%D9%8A%D8%AE_%D8%A7%D9%84%D8%AB%D9%84%D8%A7%D8%AB%D9%8A%D8%A2%D8%B1%D8%B3%D9%86%DB%8C%DA%A9_%D8%AA%D8%B1%DB%8C%D8%A7%D9%88%DA%A9%D8%B3%DB%8C%D8%AF%D0%90%D1%80%D1%81%D0%B5%D0%BD%D0%B8%D0%BA%C3%92xid_d%27ars%C3%A8nic(III)P%C4%AD-s%C5%8FngCategory:Arsenic_trioxideOxid_arsenit%C3%BDArsenikArsen(III)-oxid%CE%A4%CF%81%CE%B9%CE%BF%CE%BE%CE%B5%CE%AF%CE%B4%CE%B9%CE%BF_%CF%84%CE%BF%CF%85_%CE%B1%CF%81%CF%83%CE%B5%CE%BD%CE%B9%CE%BA%CE%BF%CF%8DArsenic_trioxideArsenikoTri%C3%B3xido_de_ars%C3%A9nicoDiarseentrioksiid%D8%A2%D8%B1%D8%B3%D9%86%DB%8C%DA%A9_%D8%AA%D8%B1%DB%8C%E2%80%8C%D8%A7%DA%A9%D8%B3%DB%8C%D8%AFArseenitrioksidiAnhydride_ars%C3%A9nieux%D7%90%D7%A8%D7%A1%D7%A0%D7%99%D7%A7_%D7%98%D7%A8%D7%99%D7%90%D7%95%D7%A7%D7%A1%D7%99%D7%93%E0%A4%86%E0%A4%B0%E0%A5%8D%E0%A4%B8%E0%A5%87%E0%A4%A8%E0%A4%BF%E0%A4%95_%E0%A4%9F%E0%A5%8D%E0%A4%B0%E0%A4%BE%E0%A4%87%E0%A4%91%E0%A4%95%E0%A5%8D%E0%A4%B8%E0%A4%BE%E0%A4%87%E0%A4%A1Arz%C3%A9n-trioxidArsen_trioksidaOssido_arsenioso%E4%B8%89%E9%85%B8%E5%8C%96%E4%BA%8C%E3%83%92%E7%B4%A0%EC%82%BC%EC%82%B0%ED%99%94_%EB%B9%84%EC%86%8C%E0%B4%86%E0%B4%B4%E0%B5%8D%E0%B4%B8%E0%B4%A8%E0%B4%BF%E0%B4%95%E0%B5%8D_%E0%B4%9F%E0%B5%8D%E0%B4%B0%E0%B4%AF%E0%B5%8B%E0%B4%95%E0%B5%8D%E0%B4%B8%E0%B5%88%E0%B4%A1%E0%B5%8DArseen(III)oxideArsenikkArsenikkTritlenek_diarsenuArszenikTri%C3%B3xido_de_ars%C3%AAnioTrioxid_de_arsen%D0%9E%D0%BA%D1%81%D0%B8%D0%B4_%D0%BC%D1%8B%D1%88%D1%8C%D1%8F%D0%BA%D0%B0(III)Arsenik_trioksidArsenic_trioxideOxid_arzenit%C3%BDArzenov_trioksidArsenik_trioksidArseniktrioxid%E0%AE%86%E0%AE%B0%E0%AF%8D%E0%AE%9A%E0%AE%A9%E0%AE%BF%E0%AE%95%E0%AF%8D_%E0%AE%AE%E0%AF%82%E0%AE%B5%E0%AE%BE%E0%AE%95%E0%AF%8D%E0%AE%9A%E0%AF%88%E0%AE%9F%E0%AF%81
about
P3781
Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic LeukaemiaCombination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesArsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to TreatmentStudy of Arsenic Trioxide in Small Cell Lung CancerCytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid LeukemiaTreatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple MyelomaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaArsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple MyelomaArsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic SyndromesArsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaArsenic Trioxide in Treating Patients With Advanced Hematologic CancerArsenic Trioxide in Treating Patients With Advanced Solid TumorsMelphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple MyelomaArsenic Trioxide in Treating Patients With Metastatic Kidney CancerArsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyLow Dose Arsenic Trioxide as a Potential Chemotherapy ProtectorClinical Trial of Arsenic Trioxide Combined Chemotherapy in the Treatment of Stage 4 NeuroblastomaArsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid LeukemiaLong-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic LeukemiaArsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
P4844
probucolclarithromycinpimozideazithromycindroperidol(RS)-methadoneerythromycinhaloperidoldofetilideibutilidechlorpromazineanagrelidedronedarone(RS)-citalopramondansetronamiodaronequinidinesotalolcocainepentamidineprocainamideterfenadinesevofluraneflecainidesulpiridechloroquineastemizoleescitalopramdomperidonemoxifloxacindisopyramidecisapridebepridilthioridazinemesoridazineHalofantrinesparfloxacin
P769
UtrýchOpposite effect of NF-kB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arseniteThe past and future of occupational exposure limitsIdentification of potential sources of arsenic exposure during scrapyard work at a former uranium enrichment facilityMeasurement of multiple inorganic arsenic speciesChronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cellsSignaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen speciesIntracellular signal transduction of cells in response to carcinogenic metalsЭСБЕ / Белый мышьяк, в минералогииArsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemiaThe Mcl-1L protein confers resistance of human non-small cell lung carcinoma NL20TA cells to arsenic trioxide-induced apoptosisExposure surveillance of museum workers to residual pesticides on collectionsWorkplace air -- determination of particulate arsenic and arsenic compounds and arsenic trioxide vapour -- method by hydride generation and atomic absorption spectrometryArsenic Trioxide ProductionArsenic contamination near a copper smelterMeasurement of Exposure to Arsenic in the Occupational SettingOccupational exposure to arsine. An epidemiologic reappraisal of current standardsHealth hazard evaluation report: HHE-80-19-765, Jeannette Glass Company, Jeannette, PennsylvaniaHHE Report, No. HETA-81-9-1052, Globe Battery Plant Corporation, Bennington, VermontElevated levels of antibodies against xenobiotics in a subgroup of healthy subjectsNIOSH Manual of Analytical Methods, Third Edition, Volume 1Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation.Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells.Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.Arsenic contamination in an abandoned building - Ohio[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia]
P921
description
Farmacevtska substanca
@sl
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Arseen(III)oxide
@nl
Arseenitrioksidi
@fi
Arsen trioksida
@id
Arsen(III)-oxid
@de
Arsenic trioxide
@en-ca
Arsenic trioxide
@en-gb
Arsenic
@ro
Arsenik trioksit
@tr
Arseniko
@eo
Arsenolit
@sh
type
label
Arseen(III)oxide
@nl
Arseenitrioksidi
@fi
Arsen trioksida
@id
Arsen(III)-oxid
@de
Arsenic trioxide
@en-ca
Arsenic trioxide
@en-gb
Arsenic
@ro
Arsenik trioksit
@tr
Arseniko
@eo
Arsenolit
@sh
altLabel
Acide Arsenieux
@en
Anhydride Arsenieux
@en
Arseni Trioxydum
@en
Arsenic Blanc
@en
Arsenic Oxidearsenous Trioxide
@en
Arsenic oxide
@en
Arsenic trioxide
@en
Arsenic(III) oxide
@en
Arsenico bianco
@it
Arsenigen Saure
@en
prefLabel
Arseen(III)oxide
@nl
Arseenitrioksidi
@fi
Arsen trioksida
@id
Arsen(III)-oxid
@de
Arsenic trioxide
@en-ca
Arsenic trioxide
@en-gb
Arsenic
@ro
Arsenik trioksit
@tr
Arseniko
@eo
Arsenolit
@sh